維信諾(002387.SZ):籌劃控制權變更事項 3月1日起停牌
格隆匯 2 月 28日丨維信諾(002387.SZ)公佈,於2021年2月26日收到控股股東西藏知合資本管理有限公司(以下簡稱"西藏知合")的通知,獲悉西藏知合擬向交易對方轉讓其持有的1.60億股公司股票,約佔公司股份總數的11.70%,且交易對方正在與公司第二大股東崑山經濟技術開發區集體資產經營有限公司籌劃簽署《一致行動協議》,前述事項可能導致公司控制權發生變更。此次交易對方為國資公司,主要從事股權投資,此次交易相關事項涉及國資有關部門審批。
經公司向深圳證券交易所申請,公司股票(股票簡稱:維信諾,股票代碼:002387)自2021年3月1日(星期一)開市起停牌,預計停牌時間不超過5個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.